 |
LORI QUEISSER
Senior Vice President, Global Compliance and Business Practices
Schering-Plough Corporation
Kenilworth, New Jersey
Lori Queisser is senior vice president, Global Compliance and Business Practices, for Schering-Plough Corporation.
Queisser joined Schering-Plough in February 2007. She is responsible for the development of global standards, training and enforcement programs for compliance in all areas of the company, including manufacturing, R&D programs, clinical trials, and sales and marketing, as well as for the implementation of privacy policies for customers, patients, employees and other stakeholders.
Queisser came to Schering-Plough from Eli Lilly and Company, where she was most recently vice president, Chief Compliance Officer. Prior to that, she held the position of executive director, auditing. Also while at Eli Lilly, she held a number of other financial, auditing and business process improvement positions of increasing responsibility. Before joining Eli Lilly, Queisser worked as an auditor with Ernst & Young.
Queisser holds a B.S. degree from the Indiana University School of Business. She is co-chair of the Pharmaceutical Compliance Forum.
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
|
|
About Us
